Prosecution Insights
Last updated: July 17, 2026

Howson & Howson LLP

73 pending office actions • 31 clients • 67 examiners • 46 art units • 0 of 73 (0%) have an AI response strategy ready • 73 patents granted in the last 365 days

Quality Metrics (n=5618 apps, methodology: how we score firms)

78.3%
Allowance Rate
n=5618
+0.66σ
Allowance Rate (norm)
n=5618
3.5
OAs to Allowance
n=2353
-0.14σ
OAs to Allow (norm)
n=2353
1128 days
Time to Allowance
n=2353
+17.2pp
Interview Lift
n=5618
23.8%
RCE Rate
n=5618
3.1%
Appeal Rate
n=5618

Rejection Performance (% of received rejections ultimately overcome)

69.4%
§101 Overcome
n=49
79.7%
§102 Overcome
n=311
78.3%
§103 Overcome
n=1408
83.9%
§112 Overcome
n=422

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
29%
Top-3 CPC Share
n=5618
7
Practitioners
n=5618
802.6
Apps / Practitioner
n=5618

Portfolio Summary

73
Total Pending OAs
41
Non-Final OAs
30
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 44 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

27
Overdue
4
Due this week
6
Due this month
5
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 44 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (27)Due ≤ 7 days (4)Due ≤ 30 days (6)Due ≤ 60 days (5)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (3%)
43
Medium (59%)
15
Easy (21%)
13
Unknown (18%)

Rejection Statute Mix

BucketCases
§101 only2 (3%)
§103 only37 (51%)
§102 only6 (8%)
§112 only10 (14%)
Double-patenting only5 (7%)
No statute on record13 (18%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

59
Life Sciences
81% of docket
0
Information Tech
0% of docket
1
Communications
1% of docket
1
Semiconductors
1% of docket
9
Mechanical / Eng
12% of docket
3
Business / Other
4% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

730 h
Manual time on pending OAs
146 h
Time saved (low, 20%)
255 h
Time saved (mid, 35%)
6.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SWITZER, JULIET CAROLINE 3 42.0% +54.0%
HILL, KEVIN KAI 3 36.1% +33.4%
KONOPKA, CATHERINE ANNE 2 58.6% +65.0%
YU, DAVID TUYANG 2 100.0% +0.0%
REID, MICHAEL ROBERT 1 79.0% +19.5%
HIBBERT, CATHERINE S 1 59.2% +48.1%
THROOP, MYLES A 1 58.3% +40.8%
CANNON, RYAN SMITH 1 55.1% +37.0%
TCHERKASSKAYA, OLGA V 1 55.3% +46.2%
AYALEW, TINSAE B 1 75.6% +9.2%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18254893 COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN SYNDROME YU, DAVID TUYANG 15d overdue
17523492 Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12 YU, DAVID TUYANG

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18042730 COMPOSITIONS AND METHODS FOR EARLY DETECTION OF OSTEOPOROSIS LUSI, ELLIS FOLLETT 79d overdue
18251075 BREATH BIOMARKERS OF SARS-COV-2 IN CHILDREN AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF COVID-19 WEARE, MEREDITH H

Interview Candidates (13)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17995539 REAWAKENING OF DORMANT TUMOR CELLS BY MODIFIED LIPIDS DERIVED FROM STRESS ACTIVATED NEUTROPHILS KONOPKA, CATHERINE ANNE 182d overdue
18863982 Hybrid Solar Panel and Photovoltaic and Thermal Roof CANNON, RYAN SMITH 120d overdue
18467927 METHODS OF SPECIFICALLY LABELING NUCLEIC ACIDS USING CRISPR/CAS SWITZER, JULIET CAROLINE 49d overdue
18257504 CHEMICALLY MODIFIED CRISPR-CAS13 GUIDE RNAS KONOPKA, CATHERINE ANNE 38d overdue
18868739 SUPPORT AND RESTRAINT SYSTEM FOR THE HUMAN BODY, OR FOR A SEGMENT OF THE HUMAN BODY, PROVIDED WITH RETAINING MEANS THROOP, MYLES A 30d overdue
19051398 METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR HIBBERT, CATHERINE S 3d overdue
18306548 COMPOSITIONS AND METHODS FOR DIAGNOSING LUNG CANCERS USING GENE EXPRESSION PROFILES SWITZER, JULIET CAROLINE 83d
19133922 VALVE REID, MICHAEL ROBERT

Client Portfolio (31 clients)

Top Art Units

Art UnitApps
16356
16344
16384
16723
16363
16823
16313
16582
17942
16372

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19133922 VALVE Fujikiin Incorporated REID, MICHAEL ROBERT 3753 §103 Non-Final OA Pending May 29, 2025
19051398 METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR The Trustees of the University of Pennsylvania HIBBERT, CATHERINE S 1658 Other Non-Final OA 3d overdue Pending Feb 12, 2025
18868739 SUPPORT AND RESTRAINT SYSTEM FOR THE HUMAN BODY, OR FOR A SEGMENT OF THE HUMAN BODY, PROVIDED WITH RETAINING MEANS Pro Medicare S.r.l. THROOP, MYLES A 3673 §112 Final Rejection 30d overdue Pending Nov 23, 2024
18863982 Hybrid Solar Panel and Photovoltaic and Thermal Roof Sic Divisione Elettronica S.R.L.U. CANNON, RYAN SMITH 1726 §103 Non-Final OA 120d overdue Pending Nov 07, 2024
18853162 BIODEGRADABLE LIPIDOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF FOR LIVER TARGETED DELIVERY The Trustees of the University of Pennsylvania TCHERKASSKAYA, OLGA V DP Non-Final OA Pending Oct 01, 2024
18779936 METHOD AND DEVICE FOR WASHING/CLEANING GRANULAR MATERIAL FROM SLAG AND WASHING/CLEANING BOTTOM/BOILER ASH FROM A THERMAL WASTE TREATMENT, AND MINERAL RESIDUE AND RECYCLING MATERIAL H-U-R Hamburg GmbH Hamburger-Umwelt-Recyclingtechnologien AYALEW, TINSAE B 1711 §103 Final Rejection 23d Pending Jul 22, 2024
18726026 OXIDE FILM AND OXIDE SPUTTERING TARGET JX Advanced Metals Corporation BERMAN, JASON 1794 §103 Final Rejection Pending Jul 01, 2024
18693672 INNOVATIVE BIOTECHNOLOGICAL SYSTEMS FOR THE DETECTION OF CELLULAR OR MOLECULAR ANALYTES Alma Mater Studiorum - Universita' Di Bologna ZEMAN, ROBERT A 1645 §103 Non-Final OA Pending Mar 20, 2024
18426877 Treatment of Homologous Recombination Deficient Cancers Sinai Health System STEELE, AMBER D 1658 Other Final Rejection 4d overdue Pending Jan 30, 2024
18392854 COMPOSITIONS COMPRISING A LECITHIN CHOLESTEROL ACYLTRANSFERASE VARIANT AND USES THEREOF The Trustees of the University of Pennsylvania GROOMS, TIFFANY NICOLE 1637 Other Non-Final OA 15d Pending Dec 21, 2023
18570181 AUTOMATED SYSTEM FOR CARRYING OUT CAPPING TESTS Arol S.p.A. PARCO JR, RUBEN C 2853 §112 Non-Final OA 56d Pending Dec 14, 2023
18567629 RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR LESCH-NYHAN DISORDERS AND USES THEREOF The Trustees of the University of Pennsylvania GOMEZ RODRIGUEZ, JULIO WASHINGTON §103 Non-Final OA Pending Dec 06, 2023
18567168 VESSEL PROVIDED WITH AN IMPROVED AIR CIRCULATION SYSTEM 3J Marine S.r.l. BURGESS, MARC R 3615 §103 Non-Final OA 22d Pending Dec 05, 2023
18519972 METHODS AND COMPOSITIONS FOR TREATING METASTATIC BREAST CANCER AND OTHER CANCERS IN THE BRAIN The Trustees of the University of Pennsylvania ARON, KIMBERLY A 1633 DP Non-Final OA Pending Nov 27, 2023
18513571 FILTER MESH Markert Filtration GmbH MENDOZA, WILSON GALLARDO 1772 §103 Non-Final OA 46d Pending Nov 19, 2023
18562293 SPUTTERING TARGET AND METHOD FOR MANUFACTURING SAME JX Metals Corporation OTT, PATRICK S 1794 §103 Final Rejection Pending Nov 18, 2023
18561376 SUPPORTING ARRANGEMENT FOR A CARRIED LOAD, MORE PARTICULARLY A LOAD CARRIED ON A SHIP 3J Marine S.r.l. VENNE, DANIEL V 3615 §112 Non-Final OA 3d overdue Pending Nov 16, 2023
18556668 COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS UNIVERSITY OF SASKATCHEWAN CHEN, STACY BROWN 1672 §112 Non-Final OA Pending Oct 21, 2023
18491078 Nucleic Acid Molecules Encoding Indoleamine 2,3-Dioxygenase-2 Lankenau Institute For Medical Research ORWIG, KEVIN S 3991 §102 Non-Final OA 49d overdue Pending Oct 20, 2023
18487647 Foetal Monitoring System Vitaltrace Pty Ltd. GUERRERO ROSARIO, ANA VERUSKA 3794 §103 Final Rejection Pending Oct 16, 2023
18485352 COMPOSITIONS USEFUL FOR TREATING SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA) The Trustees of the University of Pennsylvania HUDSON, AMY ROSE 1636 Non-Final OA Pending Oct 12, 2023
18285411 LAYERED BODY HAVING FUNCTION AS TRANSPARENT ELECTROCONDUCTIVE FILM AND METHOD FOR PRODUCING SAME, AND OXIDE SPUTTERING TARGET FOR SAID LAYERED BODY PRODUCTION JX Metals Corporation SAMPLE, DAVID R 1784 §102 Non-Final OA 124d overdue Pending Oct 03, 2023
18282890 THERAPEUTIC LENSES FOR USE AS OCULAR BANDAGE AND SIMULTANEOUSLY FOR THE ADMINISTRATION OF EYE DROPS Eye Pharma Spa MELLER, MICHAEL V 1655 §103 Non-Final OA 59d overdue Pending Sep 19, 2023
18467927 METHODS OF SPECIFICALLY LABELING NUCLEIC ACIDS USING CRISPR/CAS Drexel University SWITZER, JULIET CAROLINE 1682 Other Non-Final OA 49d overdue Pending Sep 15, 2023
18446153 METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING EMETOGENIC DRUG-RELATED NAUSEA Lankenau Institute For Medical Research SAEED, ALI S 1616 Other Non-Final OA 4d overdue Pending Aug 08, 2023
18276050 Surfacing Device Tether End Component The Leisure Collective International Pty Ltd SCHATZ, CHRISTOPHER T 1746 §103 Non-Final OA Pending Aug 07, 2023
17906173 TARGETED DELIVERY OF EXTRACELLULAR VESICLES Evox Therapeutics Ltd. HAMA, JOANNE 1647 §103 Final Rejection 71d Pending Jul 27, 2023
18263085 COMPOSITIONS AND METHODS FOR TREATMENT OF NIEMANN PICK TYPE A DISEASE The Trustees of the University of Pennsylvania TATGE, LEXUS MARC 1637 §102 Non-Final OA Pending Jul 26, 2023
18260786 COMPOSITIONS FOR TREATING FRIEDREICH'S ATAXIA The Trustees of the University of Pennsylvania MIANO, JOSEPH PAUL 1631 Other Non-Final OA 27d Pending Jul 09, 2023
17999987 COMPOSITIONS AND METHODS FOR NEGATIVE SELECTION OF NAIVE T AND B CELLS WITH A SINGLE ANTIBODY Biomagnetic Solutions LLC CANDELARIA, JULIANA IRENE 1634 Other Non-Final OA 5d overdue Pending Jun 15, 2023
18257504 CHEMICALLY MODIFIED CRISPR-CAS13 GUIDE RNAS New York University KONOPKA, CATHERINE ANNE 1635 Other Non-Final OA 38d overdue Pending Jun 14, 2023
18041627 Methods and Compositions for Inhibiting Viral Infection New York University OH, TAYLOR V 1625 §103 Non-Final OA Pending Jun 02, 2023
18255154 NOVEL COMPOSITIONS WITH TISSUE-SPECIFIC TARGETING MOTIFS AND COMPOSITIONS CONTAINING SAME The Trustees of the University of Pennsylvania BARRERA, IMMACULADA 1671 §103 Non-Final OA 86d overdue Pending May 31, 2023
18254893 COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN SYNDROME The Trustees of the University of Pennsylvania YU, DAVID TUYANG 1635 §103 Non-Final OA 15d overdue Pending May 30, 2023
18251075 BREATH BIOMARKERS OF SARS-COV-2 IN CHILDREN AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF COVID-19 The Children's Hospital of Philadelphia WEARE, MEREDITH H 3791 §101 Final Rejection Pending Apr 28, 2023
18306548 COMPOSITIONS AND METHODS FOR DIAGNOSING LUNG CANCERS USING GENE EXPRESSION PROFILES The Wistar Institute SWITZER, JULIET CAROLINE 1682 Other Final Rejection 83d Pending Apr 25, 2023
18250459 METHODS AND COMPOSITIONS FOR NUTRITIONAL SUSTENANCE AND WASTE SCAVENGING IN TISSUE INJURIES AND WOUNDS New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special AL-AWADI, DANAH J 1615 §103 Non-Final OA 26d overdue Pending Apr 25, 2023
18249591 BORONIC ESTERS AND COATINGS COMPRISING THEM Petroliam Nasional Berhad (Petronas) BUTCHER, ROBERT T 1764 §103 Non-Final OA Pending Apr 19, 2023
18175405 TOOL ARRANGEMENT FOR APPLICATION AND/OR RELEASE OF NUT TYPE FASTENERS Engentus Pty Ltd. SAETHER, FLEMMING 3675 §103 Final Rejection 71d overdue Pending Feb 27, 2023
18042729 VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES The Trustees of the University of Pennsylvania RAVINDRA, KRISHNA NUGGEHALLI 1636 Other Non-Final OA 99d overdue Pending Feb 23, 2023
18042730 COMPOSITIONS AND METHODS FOR EARLY DETECTION OF OSTEOPOROSIS New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special LUSI, ELLIS FOLLETT 1677 §101 Final Rejection 79d overdue Pending Feb 23, 2023
18004148 A DNA PLASMID SARS-CORONA VIRUS-2/COVID-19 VACCINE Statens Serum Institut BUCKMASTER, MARLENE VRENI 1672 §103 Non-Final OA 60d overdue Pending Jan 03, 2023
18061633 GENE THERAPY FOR OCULAR DISORDERS The Trustees of the University of Pennsylvania HILL, KEVIN KAI 1638 §103 Non-Final OA Pending Dec 05, 2022
18000010 METHODS AND COMPOSITIONS FOR TREATING, PREVENTING THE ONSET AND/OR SLOWING PROGRESSION OF OSTEOARTHRITIS New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special LI, RUIXIANG 1674 §112 Non-Final OA 7d Pending Nov 28, 2022
17998330 COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE The Trustees of the University of Pennsylvania RIGA, MICHAEL ANGELO 1634 §103 Final Rejection 34d Pending Nov 09, 2022
17922196 Method, System and Apparatus for Investigating or Assessing Eye or Pupil Movement Neurotologix Pty Ltd. WESTFALL, SARAH ANN 3791 §103 Final Rejection Pending Oct 28, 2022
17997110 COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY The Trustees of the University of Pennsylvania SPENCER, ANDREA LYNNE MORRIS 1631 Other Non-Final OA 6d Pending Oct 25, 2022
17997108 COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY The Trustees of the University of Pennsylvania ABBOTT, KODYE LEE 1634 §112 Final Rejection Pending Oct 25, 2022
17996379 LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION Statens Serum Institut BROWE, DAVID 1617 §112 Non-Final OA Pending Oct 17, 2022
18047189 COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS The Children's Hospital of Philadelphia SHIN, DANA H 1635 §102 Non-Final OA 2d overdue Pending Oct 17, 2022
17995539 REAWAKENING OF DORMANT TUMOR CELLS BY MODIFIED LIPIDS DERIVED FROM STRESS ACTIVATED NEUTROPHILS The Wistar Institute KONOPKA, CATHERINE ANNE 1635 §103 Non-Final OA 182d overdue Pending Oct 05, 2022
17936058 METHOD FOR REDUCING LUNG INFLAMMATION Respirion Pharmaceuticals Pty Ltd. RAMOS LEWIS, JOSMALEN MILAGROS 1621 §103 Final Rejection 38d overdue Pending Sep 28, 2022
17904899 TREATING AUTOSOMAL DOMINANT BESTROPHINOPATHIES AND METHODS FOR EVALUATING SAME The Trustees of the University of Pennsylvania HILL, KEVIN KAI 1638 DP Final Rejection Pending Aug 24, 2022
17792441 HIGH-PURITY MOLYBDENUM OXYCHLORIDE AND MANUFACTURING METHOD THEREFOR Toho Titanium Co., Ltd. LACLAIR, LOGAN EDWARD 1736 §103 Final Rejection 60d Pending Jul 13, 2022
17787433 NOVEL DRUGGABLE TARGETS FOR THE TREATMENT OF INFLAMMATORY DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND METHODS FOR DIAGNOSIS AND TREATMENT USING THE SAME The Children's Hospital of Philadelphia KAPUSHOC, STEPHEN THOMAS 1683 §112 Final Rejection 56d Pending Jun 20, 2022
17834072 METHOD FOR FINDING PRODUCTS IN A NETWORK Patty'S GmbH BROUGHTON, KATHLEEN M 2661 §103 Final Rejection Pending Jun 07, 2022
17781945 NANOPARTICLE COMPOSITIONS AND METHODS OF USE The Trustees of the University of Pennsylvania REDDIG, PETER J 1646 §103 Final Rejection 85d overdue Pending Jun 02, 2022
17641650 NOVEL GENETIC MARKERS FOR POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF THE SAME The Children's Hospital of Philadelphia SWITZER, JULIET CAROLINE 1682 §103 Final Rejection Pending Mar 09, 2022
17641665 COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS The Children's Hospital of Philadelphia YOUNGBLOOD, WILLIAM JUSTIN 1629 Other Non-Final OA 11d overdue Pending Mar 09, 2022
17672438 COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM DEPOSITION AND PRODUCTION The Trustees of the University of Pennsylvania DABKOWSKI, ERINNE R 1654 DP Final Rejection Pending Feb 15, 2022
17634968 NOVEL LOX-1 ANTIBODY COMPOSITIONS, LOX1 NEUTRALIZATION ASSAY AND METHODS OF TREATMENT USING SAME The Wistar Institute SHUPE, ELIZABETH A 1643 §112 Non-Final OA 162d overdue Pending Feb 12, 2022
17626598 METHODS AND COMPOSITIONS FOR SCALABLE POOLED RNA SCREENS WITH SINGLE CELL CHROMATIN ACCESSIBILITY PROFILING New York University YOUNG, BRIAN ELLIS 1684 §103 Final Rejection 30d Pending Jan 12, 2022
17523492 Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12 The Trustees of the University of Pennsylvania YU, DAVID TUYANG 1635 §102 Final Rejection Pending Nov 10, 2021
17603993 COMPOSITIONS FOR REGULATING AND SELF-INACTIVATING ENZYME EXPRESSION AND METHODS FOR MODULATING OFF-TARGET ACTIVITY OF ENZYMES The Trustees of the University of Pennsylvania REGA, KYLE THOMAS 1636 §103 Final Rejection Pending Oct 15, 2021
17601581 COMPOSITIONS AND METHODS FOR IN UTERO GENE EDITING FOR MONOGENIC LUNG DISEASE The Trustees of the University of Pennsylvania BATES, KEENAN ALEXANDER 1631 §103 Non-Final OA 5d Pending Oct 05, 2021
17601542 The Treatment of Protein Aggregation Diseases Pharmakure Limited JOHNSON, ALLISON MARIE 1638 §102 Final Rejection 125d overdue Pending Oct 05, 2021
17435365 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY The Trustees of the University of Pennsylvania SULLIVAN, STEPHANIE LAUREN 1635 §103 Final Rejection 27d Pending Aug 31, 2021
17424363 MICROCATHETER FOR THERAPEUTIC AND/OR DIAGNOSTIC INTERVENTIONS IN THE SUBARACHNOID SPACE The Trustees of the University of Pennsylvania LUU, TIMOTHY TUAN 3795 §103 Non-Final OA Pending Jul 20, 2021
17356146 IN VIVO DETECTION OF EGFR MUTATION IN GLIOBLASTOMA VIA MRI SIGNATURE CONSISTENT WITH DEEP PERITUMORAL INFILTRATION The Trustees of the University of Pennsylvania SCHULTZHAUS, JANNA NICOLE 1685 §103 Non-Final OA 36d overdue Pending Jun 23, 2021
17416311 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY The Trustees of the University of Pennsylvania CONNORS, ALEXANDRA F 1634 §103 Final Rejection Pending Jun 18, 2021
17097997 COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION The Trustees of the University of Pennsylvania HILL, KEVIN KAI 1638 DP Non-Final OA Pending Nov 13, 2020
16975541 NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR The Trustees of the University of Pennsylvania WANG, RUIXUE 1672 §103 Final Rejection Pending Aug 25, 2020
16943947 Methods for Monitoring Polymorphonuclear Myeloid Derived Suppressor Cells and Compositions and Methods of Treatment of Cancer The Wistar Institute FORD, VANESSA L 1674 §112 Final Rejection 6d Pending Jul 30, 2020

Managing Howson & Howson LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month